64 results on '"Fogelman I"'
Search Results
2. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells
3. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)
4. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA
5. Late Low-Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density
6. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene
7. Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer
8. Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study
9. Corrigendum to “Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)” [Bone 48 (2011) 1127–1132]
10. Metabolic disturbances identified by spect-ct in patients with a clinical diagnosis of sacroiliac joint incompetence
11. Corrigendum to “Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)” [Bone 48 (2011) 1127–1132]
12. Bone turnover at the spine and hip measured using 18F-PET
13. Bone health in breast cancer survivors following adjuvant bisphosphonate therapy: AZURE quantitative bone scan sub-study
14. PL7.2. PET and bone metastases
15. Comparison of myocardial gated spect, planar radionuclide ventriculography and echocardio-graphy in evaluating left ventricular ejection fraction, wall motion and thickening
16. Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer
17. Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: A potential contributory factor in steroid-induced osteoporosis
18. The ZEBRA study: Reversibility of bone mineral density of pre-/perimenopausal patients with node-positive early breast cancer after treatment with Zoladex™
19. Premenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women
20. A clinical profile of back pain and disability in patients with spinal osteoporosis
21. Insulin-like Growth Factor-I and Bone Mineral Density
22. Effect of a GnRH analogue on bone mass in premenopausal patients with mastalgia
23. A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase
24. Selection of patients with breast cancer for routine follow-up bone scans
25. The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor.
26. Osteocalcin: a potential marker of metastatic bone disease and response to treatment
27. Detection of an elusive osteoid osteoma using a registration bone scan
28. Registration bone scan in the evaluation of wrist pain
29. Glucocorticoids and æstrogens in the management of hypercalcaemia
30. The role of bone scanning in paget's disease
31. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease
32. SKELETAL UPTAKE OF DIPHOSPHONATE: Method for Prediction of Post-menopausal Osteoporosis
33. FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE
34. CLINICAL VALUE OF ADRENAL ANDROGEN MEASUREMENT IN THE DIAGNOSIS OF DELAYED PUBERTY
35. HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITY
36. HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?
37. Scintigraphic evaluation of the painful prosthetic joint: A comparison of gallium-67 citrate and indium-111 labelled leucocyte imaging
38. Ablation of mediastinal parathyroid adenomas by superselective embolization of the internal mammary artery with alcohol
39. The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants
40. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women
41. Are liver metastases involved in the pathogenesis of hypercalcaemia of malignancy (HM)?
42. Biochemical assessment predicts radiological response in bone metastases from breast cancer
43. Osteopenia in anorexia nervosa: The effect of recovery
44. The effect of etidronate disodium on skeletal metabolism following the menopause
45. Combined oral contraception and skeletal bone mass
46. Absorption of oral diphosphonate in normal subjects
47. “Low dose” disodium etidronate causes intermittent inhibition of bone mineralization and focal osteomalacia in Paget's disease
48. A comparison of one and two day protocols for ferforminc Tc99mTetrofosmine myocardial studies
49. Breast cancer and osteoporosis—A bridge at last
50. Another look. at hypercalcemia of malignancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.